Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AESGP: ‘No Evidence’ Of Antimicrobial Resistance With OTC Antifungals Or Antivirals

Mar 31 2025

• By David Ridley

AESGP finds no evidence of AMR with OTC antimicrobials • Source: Shutterstock

Related Content

Kenvue’s Carlton Lawson: Reverse-Switching Antimicrobials ‘Not The Answer’ To AMR

Dec 09 2024

Reverse-Switching OTC Antimicrobials Could Cost Europe An Additional €10bn Per Year

Nov 18 2024

OTCs ‘Notably Absent’ From UNGA High Level Antimicrobial Resistance Meeting

Oct 22 2024

PAGB: AMR Issue Should Be About ‘Stewardship’ Not Making OTCs Prescription-Only

Sep 24 2024

WHO Resolution Targets OTC Antimicrobials, Industry Insists Problem Is Rx Misuse

Aug 13 2024

Study: OTC Nasal Sprays Reduce Respiratory Illness Duration And Help Tackle AMR

Jul 30 2024

AESGP Meeting: Industry Must Be ‘Organized, Bold And Unapologetic’ About Value Of Self-Care

Jun 06 2024

ENVI: Prescription Requirement Only With Evidence Of Antimicrobial Resistance

Apr 05 2024

More from Europe

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window